Effect of a cytotoxic analog of LH-RH (T-98) on the growth of estrogen-dependent MXT mouse mammary cancers: Correlations between growth characteristics and EGF receptor content of tumors

被引:13
作者
Szepeshazi, K
Schally, AV
Halmos, G
Szoke, B
Groot, K
Nagy, A
机构
[1] VET ADM MED CTR,INST ENDOCRINE POLYPEPTIDE & CANC,NEW ORLEANS,LA 70146
[2] TULANE UNIV,SCH MED,DEPT MED,SECT EXPT MED,NEW ORLEANS,LA 70146
关键词
experimental breast cancer; LH-RH agonist; cytotoxic compounds; EGF receptors; organ distribution; AgNOR; apoptosis;
D O I
10.1007/BF01806208
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Female BDF mice bearing estrogen-dependent MXT mouse mammary cancers were treated for 4 weeks with a cytotoxic analog of luteinizing hormone-releasing hormone (LH-RH), T-98 (agonist [D-Lys(6)]LH-RH linked to glutaryl-2(hydroxymethyl)anthraquinone). The effects of T-98 were compared to those of equimolar amounts of the cyto toxic moiety 2-(hydroxymethyl)anthraquinone hemiglutarate (G-HMAQ) and carrier LH-RH agonist [D-Lys(6)]LH-RH. Both T-98 and [D-Lys(6)]LH-RH significantly inhibited the growth of MXT cancers, but G-HMAQ had only a minor non-significant effect. Cytotoxic analog T-98 and the carrier [D-Lys(6)]LH-RH had similar inhibitory hormonal activities on the pituitary-gonadal axis, but T-98 caused a larger reduction in tumor volume and decreased proliferation characteristics such as mitotic activity and AgNOR numbers in tumor cells to a greater extent than the carrier. Tumor inhibition by T-98, [D-Lys(6)]LH-RH, and ovariectomy was connected with a significant decrease in binding capacity of EGF receptors in tumor cell membranes. The concentration of EGF receptors remained high in tumors that continued to enlarge in spite of treatment and in all control untreated tumors, even those of small size. Thus, the changes in EGF receptors are likely to be the result of the therapy. Treatment with T-98 caused a greater reduction in the binding capacity of EGF receptors in tumors than [D-Lys(6)]LH-RH. This could explain the higher inhibitory effect of the cytotoxic analog on tumor growth. Since radiolabeled T98 was shown to accumulate in MXT cancers 3 hours after a subcutaneous injection, this indicates that specific targeting might play a role in the antitumor effect exerted by this cytotoxic analog.
引用
收藏
页码:129 / 139
页数:11
相关论文
共 49 条
[1]   HIGHLY POTENT METALLOPEPTIDE ANALOGS OF LUTEINIZING-HORMONE-RELEASING HORMONE [J].
BAJUSZ, S ;
JANAKY, T ;
CSERNUS, VJ ;
BOKSER, L ;
FEKETE, M ;
SRKALOVIC, G ;
REDDING, TW ;
SCHALLY, AV .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (16) :6313-6317
[2]   HIGHLY POTENT ANALOGS OF LUTEINIZING-HORMONE-RELEASING HORMONE CONTAINING D-PHENYLALANINE NITROGEN-MUSTARD IN POSITION-6 [J].
BAJUSZ, S ;
JANAKY, T ;
CSERNUS, VJ ;
BOKSER, L ;
FEKETE, M ;
SRKALOVIC, G ;
REDDING, TW ;
SCHALLY, AV .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (16) :6318-6322
[3]   FROM ADJUVANT TO NEOADJUVANT CHEMOTHERAPY IN HIGH-RISK BREAST-CANCER - THE EXPERIENCE OF THE MILAN CANCER INSTITUTE - STEINER AWARD LECTURE 1992 [J].
BONADONNA, G .
INTERNATIONAL JOURNAL OF CANCER, 1993, 55 (01) :1-4
[4]  
CARBONE PP, 1990, CANCER, V65, P2108, DOI 10.1002/1097-0142(19900501)65:9+<2108::AID-CNCR2820651404>3.0.CO
[5]  
2-F
[6]  
DERENZINI M, 1991, VIRCHOWS ARCH B, V61, P1
[7]   GONADOTROPIN-RELEASING-HORMONE (GNRH)-BINDING SITES IN HUMAN-BREAST CANCER CELL-LINES AND INHIBITORY EFFECTS OF GNRH ANTAGONISTS [J].
EIDNE, KA ;
FLANAGAN, CA ;
HARRIS, NS ;
MILLAR, RP .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1987, 64 (03) :425-432
[8]   THE USE OF LUTEINIZING-HORMONE-RELEASING HORMONE AGONISTS AND ANTAGONISTS IN GYNECOLOGICAL CANCERS [J].
EMONS, G ;
SCHALLY, AV .
HUMAN REPRODUCTION, 1994, 9 (07) :1364-1379
[9]   REGULATION OF EPIDERMAL GROWTH-FACTOR RECEPTOR BY PROGESTINS AND GLUCOCORTICOIDS IN HUMAN-BREAST CANCER CELL-LINES [J].
EWING, TM ;
MURPHY, LJ ;
NG, ML ;
PANG, GYN ;
LEE, CSL ;
WATTS, CKW ;
SUTHERLAND, RL .
INTERNATIONAL JOURNAL OF CANCER, 1989, 44 (04) :744-752
[10]   CHARACTERISTICS AND DISTRIBUTION OF RECEPTORS FOR [D-TRP6]-LUTEINIZING HORMONE-RELEASING HORMONE, SOMATOSTATIN, EPIDERMAL GROWTH-FACTOR, AND SEX STEROIDS IN 500 BIOPSY SAMPLES OF HUMAN-BREAST CANCER [J].
FEKETE, M ;
WITTLIFF, JL ;
SCHALLY, AV .
JOURNAL OF CLINICAL LABORATORY ANALYSIS, 1989, 3 (03) :137-147